Business Wire

The Melbourne Symphony Orchestra Selects Brightcove to Power New Digital Platform

Share

Brightcove Inc. (NASDAQ: BCOV), the global leader in video for business, today announced that the Melbourne Symphony Orchestra (MSO) is using Brightcove to power its new digital platform MSO.LIVE to cast the Orchestra’s 2021 season in Australia and around the world.

“Brightcove’s technology delivers a polished interface with exceptional quality of video and audio across multiple devices, to ensure we can deliver easily accessible, world-class digital experiences to all audiences,” said Sophie Galaise, Managing Director of the Melbourne Symphony Orchestra.

The MSO is a world-class orchestra with global credibility in providing enriching music experiences to audiences. MSO.LIVE offers 24-hour entertainment on-demand, live, and pre-recorded, delivering accessible and premium content as an alternative to traditional, in-person orchestral experiences. The MSO.LIVE experience is accessible, offering MSO concerts, family programming, and special events and performances from around the world.

A key driver for implementing Brightcove’s online video platform is to make performance experiences easily accessible and affordable to a wider audience, including those who are unable to attend in-person concerts.

The MSO’s main focus is to optimise its content delivery experience to retain existing orchestral music fans and attract new audiences from around the world to the MSO.LIVE platform. New performances are released monthly, and MSO.LIVE members are able to view content across devices and connected TVs.

Using Brightcove, MSO.LIVE demonstrates innovation within the Australian arts community by offering a contemporary content library personalised to audience preferences. “Among other criteria, we selected Brightcove as their local team of experts had the capabilities to integrate customer data with our CRM system,” said Ms. Galaise.

MSO.LIVE offers a range of traditional and contemporary content from both the MSO and other world-class orchestras from around the world, such as the Berliner Philharmoniker and Royal Concertgebouw Orchestra.

MSO.LIVE is priced at $15 per month or $144 per year for an annual subscription, or audiences can subscribe to a one-month pass or pay-per-view access. MSO.LIVE also offers a selection of free content, including programs for kids, audio, and more. View MSO.LIVE here.

“Our partnership with the Melbourne Symphony Orchestra demonstrates the power that video provides to the entertainment and music industry,” said Jennifer Smith, Chief Marketing Officer, Brightcove. “Brands in the Arts and Entertainment sector are embracing the hybrid model to allow them to grow their audiences to engage both in-person and online viewers. 2020 drove the urgency to pivot to new digital video experiences, and businesses are now embracing this as a long-term growth strategy. MSO.LIVE takes the orchestral experience to the next level and cements the MSO as a leader when it comes to the future of live performances,” said Smith.

As part of a longer-term strategy, the introduction of MSO.LIVE will help demonstrate Australia’s unique culture and celebrate the diverse talents of its local artists with the rest of the world.

About Melbourne Symphony Orchestra

Each year, the MSO engages with more than 5 million people through live concerts, TV, radio and online broadcasts, international and regional tours, recordings and education programs.

The MSO is a vital presence, both onstage and in the community, in cultivating classical music in Australia. Internationally acclaimed, the Orchestra nurtures strong cultural partnerships throughout South-East Asia. The MSO is the only Australian orchestra partnered with UNITEL, the world’s leading distributor of classical music programs for film, television and video.

The MSO regularly attracts great artists from around the globe, including Anne-Sophie Mutter, Lang Lang, Renée Fleming and Nick Cave, while bringing Melbourne’s finest musicians to the world through tours to China, Indonesia, Europe and the United States.

The nation’s first professional orchestra, the Melbourne Symphony Orchestra has been the sound of the city of Melbourne since 1906. www.mso.com.au.

About Brightcove Inc.

When video is done right, it can have a powerful and lasting effect. Hearts open. Minds change. Creativity thrives. Since 2004, Brightcove has been helping customers discover and experience the incredible power of video through its award-winning technology, empowering organisations in more than 70 countries across the globe to touch audiences in bold and innovative ways.

Brightcove achieves this by developing technologies once thought impossible, providing customer support without parallel or excuses, and leveraging the expertise and resources of a global infrastructure. Video is the world’s most compelling, exciting medium. Visit www.brightcove.com for more information. Video That Means Business™

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Brightcove Press

Meredith Duhaime
Senior Public Relations Manager
Brightcove | (603) 785-8518
mduhaime@brightcove.com

Livia Budisetio
Account Executive
LEWIS Global Communications | (61) 411 208 431
brightcoveANZ@teamlewis.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 202123.6.2021 13:00:00 CEST | Press release

Brii Biosciences (“Brii Bio”) and VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), today announced final results from a Phase 1b/2a study on BRII-179 (VBI-2601), a novel recombinant, protein-based immunotherapeutic candidate, in patients with chronic hepatitis B virus (HBV) infection. Data from the study, which evaluated the safety, antiviral activity, and immunogenicity of BRII-179 (VBI-2601) alone or admixed with interferon-alpha (IFN-α) as co-adjuvant, demonstrated that the investigational immunotherapeutic induced both B cell (antibody) and T cell responses, and was well-tolerated with no safety signals observed, in non-cirrhotic chronic hepatitis B patients under nucleos(t)ide analog (NUC) therapy. The study was led by Brii Bio in partnership with VBI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005322/en/ The data, as presented in a late-breaker e-Poster at the European Association for the Study of the Liver’s (EASL)

Amazon Becomes Largest Corporate Buyer of Renewable Energy in the U.S.23.6.2021 12:00:00 CEST | Press release

Amazon (NASDAQ: AMZN) today announced 14 new renewable energy projects in the U.S., Canada, Finland, and Spain to advance its ambitious goal to power 100% of company activities with renewable energy by 2025—five years ahead of the original target of 2030. The new projects bring Amazon’s total renewable energy investments to date to 10 gigawatts (GW) of electricity production capacity—enough to power 2.5million U.S. homes. Amazon is now the largest corporate buyer of renewable energy in the U.S. and the world. The latest utility-scale solar and wind projects will supply renewable energy for Amazon’s corporate offices, fulfillment centers, and Amazon Web Services (AWS) data centers that support millions of customers globally. These projects will also help Amazon meet its commitment to produce enough renewable energy to cover the electricity used by all Echo devices in use. These new projects support hundreds of jobs while providing hundreds of millions of dollars of investment in local c

Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System23.6.2021 12:00:00 CEST | Press release

Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today that it has raised $245 million in an oversubscribed and upsized Series D round, the largest private funding round for a dialysis device company in history. “We are delighted to attract such a strong syndicate of investors, which represents a clear vote of confidence in our innovative approach to dialysis treatment,” said John E. Milad, CEO of Quanta. “Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this mar

AntChain Launches Developer Support Program to Foster Global Collaboration on Blockchain and Other Innovations23.6.2021 10:50:00 CEST | Press release

AntChain, Ant Group’s technology brand, today launched a developer community support program at its first developer conference. The program is designed to further foster trusted industry collaboration networks with blockchain, secure computing, IoT, and other innovative technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005429/en/ Geoff Jiang, President of Ant Group’s Intelligent Technology Business Group (Photo: Business Wire) This new program will bring AntChain's technical know-how and industry experience to partners and developers across a variety of platforms. Among them, the AntChain open technology platform will serve to accelerate the development of blockchain applications as well as reduce costs, while the AntChain open business ecosystem will help connect partners and developers with complementary business opportunities and operational resources. A new talent certification system has also been put i

Teijin Receives Additional Approval in Japan for Merz’s Xeomin ® Botulinum Toxin Type A23.6.2021 10:00:00 CEST | Press release

Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly announced today that Teijin Pharma has been granted additional approval by Japan’s Ministry of Health, Labor and Welfare (MHLW) to market Xeomin® (incobotulinumtoxinA) for intramuscular injection in 50, 100 or 200 units for the treatment of lower limb spasticity. Lower limb spasticity is a symptom of upper motor neuron syndrome, which is expressed mainly by increased muscle tone of limbs and the hyperexcitability of the stretch reflex as a sequela of stroke. The main symptoms are difficulty in normal walking and increased risk of falling due to trunk instability, complicating or impeding activities in daily life. Conventional treatment of lower limb spasticity includes physical rehabilitation and the use of oral muscle relaxants or neuromuscular blockers such as botulinum toxin type A. Stefan Brinkmann,

B2B Payment Provider, ZTL, Selects Napier’s Anti-financial Crime Solutions23.6.2021 10:00:00 CEST | Press release

RegTech company, Napier, provider of advanced anti-financial crime compliance solutions, has announced its AI-led technology has been chosen by emerging Norwegian FinTech, ZTL Payment Solution. Napier will supply the B2B payment provider with Transaction Screening, Transaction Monitoring and Client Screening. These tools will enhance ZTL’s ability to identify suspicious activity related to money laundering through transaction monitoring, while also identifying potential risk of breaching sanctions with screening solutions. Founded in 2018, ZTL’s platform integrates with accounting system providers via API building blocks, providing a customized solution to facilitate for payments directly from the accounting system. ZTL will use Napier’s screening and monitoring solutions to meet regulatory compliance obligations, spot suspicious activities, and mitigate money laundering and sanctions risks. Andreas Bjerke, CEO at ZTL, said: “We are one of the first Norwegian licensed payment providers

ISAE-SUPAERO Announces Its New Specialized Master's Degree23.6.2021 09:30:00 CEST | Press release

The Institut Supérieur de l'Aéronautique et de l'Espace (ISAE-SUPAERO) in Toulouse now offers a professional certification in Artificial Intelligence and Data Science, based on the Specialized Master's Degree® AIBT (Artificial Intelligence & Business Transformation. Offered in partnership with TBS Education and IRT Saint-Exupéry, this part-time training program prepares professionals, apprentices and young graduates for this new profession that is in high demand on the job market. Admissions are open until September 15, 2021. This certification will be offered from the beginning of the new academic year to professionals, apprentices aged 25 to 30 and young graduates (Bac+5) wishing to prepare for the job of "Project Manager in Artificial Intelligence and Data Science (MS)". Certified by the RNCP number 35609, this training is entirely taught in English. This registration in the National Directory by France Compétences allows professionals to mobilize their CPF (Personal Training Accoun

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom